11
October

08:00 AM CEST

Biomanufacturing

Strategy Meeting Europe 2022

Looking into the Multimodal > Scalable > Adaptable Bioprocessing Facility of the Future

Radisson Blu Hotel, Zurich Airport

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s Manufacturing Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Biomanufacturing professionals from across Europe, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our 2022 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our upcoming strategy meeting:

Uwe Buecheler

Senior Vice President, Head of Business Units, Biopharmaceuticals Boehringer Ingelheim

Uwe Buecheler, joined <a href="https://www.boehringer-ingelheim.com/">Boehringer Ingelheim</a> (formerly Dr. Karl Thomae GmbH) in 1991. During his time at Boehringer Ingelheim he held different positions in Biopharmaceuticals in CMC Development and Regulatory Affairs, Biopharma Operations, Biological Safety and Quality. In 2006 he was appointed site head for the Boehringer Ingelheim site in Biberach, Germany and thereafter 2010 got responsible for global Biopharmaceuticals Operations including sites in Germany, Austria, USA and China. In 2016 he took over the responsibility for the Biopharma Business Unit responsible for the growing BioXcellence TM contract manufacturing business as well as supplies of Biopharmaceuticals to Boehringer Ingelheim Human Pharma. From March 2022 Uwe acted as a Senior Advisor Biopharmaceuticals to the Board of Managing Directors of Boehringer Ingelheim.
Uwe Buecheler, has conducted his Ph. D. in Molecular Biology at the University of Heidelberg and the Cancer research Center in Heidelberg. Prior to joining Boehringer Ingelheim he worked at Roche (former Boehringer Mannheim site in Penzberg). He has been awarded Professor h.c. at the University of Ulm, is chair of the Biopharma Cluster South Germany and member of various Advisory boards and (Bio-) Pharmaceutical Industry Associations.

Nora Eifler

Director DSD Project Managment CH, Drug Substance Development Biologics Novartis

Nora Eifler joined <a href="https://www.novartis.com/uk-en/">Novartis</a> in 2007 as a Lab Head for DSP Development in Biotechnology, Basel. She has held positions of increasing responsibility within Biologics since, including Technical Project Leader for early phase biologics projects, and the cross-functional role of training lead for Technical R&D. After her role as Product Steward at ESO MS&T Biopharm Sandoz, where she was responsible for CPV implementation and continuous improvement for the commercial biosimilar Binocrit (EPO), Nora re-joined Technical R&D as Technical Project Leader for NCEs in 2015. For six years, she was leading early and late phase CMC teams for the development of parenteral and topical projects. For more than one year, Nora has been leading the group of DS project leaders, working in all development phases. Nora studied Biology at the University of Heidelberg, Germany. She holds a PhD in biophysics from the Biozentrum Basel, Switzerland, on high resolution electron microscopy of membrane proteins. Nora has three children and enjoys spending as much time as possible outdoors with her family.

Christoph Herwig

Full Professor – Senior Advisor Bioprocess Technology Tu Wien

Lars Nieba

Chief Executive Officer and Chief Technology Officer Nordic Nanovector

Lorenz Rindisbacher

Senior Director, Head of Site Quality CSL Behring

See the agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Who Should Attend the Event?

Chief Executive Officers

Senior Vice Presidents

Executive Vice Presidents

Vice Presidents

Global Heads

Directors

Executive Director

Responsible For:

Quality

Quality Operations

Biomanufacturing Operations

Quality Risk Management

Process Research & Development

Bioprocess R&D

Validation Manufacturing Science & Technology

Process Design

Technical Operations

Product Supply

Quality Assurance

Quality Compliance

See Which Topics Are Discussed at the Strategy Meeting

09:00 – 10:00

Roundtable Tracks

Aligning Quality Systems With Evolving Global Health Authority Expectations

Exploring The Latest Revolution In Upstream Processing For Flexibility And Cost-Effectivity Leading To Higher Yields

Pharma 4.0: How To Effectively Integrate Advanced Process Control Based on Digital Twins Combined With Process Analytical Technology For Real-Time Release Testing (RTRT)

Addressing The Challenges In Manufacturing New Biologic Modalities: Viral Vectors, ADCs, RNA, and Cell Therapies To Build A Viable Commercial Production

11:00 – 12:00

Roundtable Tracks

Embracing The Best Strategy To Mitigate Risk And Achieve Product & Process Consistency In Place Of External Conditions Such As The Pandemic, Changing Regulations, Or Other Unseen Constraints

Looking Into Highly-Effective Tools And Techniques To Maximise Quality Output In DSP Processing

Exploring The Opportunities To Build A Cost-Effective GMP Cloud Computing Without The Need To Sacrifice Data Integrity

Understanding The Crucial Part Of Biomanufacturing To Lessen The Cost Of Advanced Therapies

Reasons To Attend the Strategy Meeting

The topic discussions on how to align QMS with different global regulatory policies provide the participants an opportunity to gain vital information needed to attain quality-compliant products across countries.

The shared challenge on raw material deficiency serves as a catalyst for the biomanufacturing key players to collectively resolve this matter. Gain pointers on how to effectively navigate digital transitions and automation leading to Bioprocessing 4.0

Learn from case studies and success stories of other pharmaceuticals and biotech companies in establishing a manufacturing system in new modalities and achieving process excellence

Obtain practical guide in interacting with CMOs to productively communicate and execute the organization’s manufacturing goals

Press play to hear what your colleagues had to say…

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

Partner with Us

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Manufacturing Europe

Biomanufacturing Strategy Meeting Europe 2023

Biomanufacturing

Strategy Meeting Europe 2022

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Radisson Blu Hotel, Zurich Airport

Fresh Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Meet Our 2022 Facilitators

Uwe Buecheler

Nora Eifler

Christoph Herwig

Lars Nieba

Lorenz Rindisbacher

See the agenda and facilitator line-up

Who Should Attend the Event?

Chief Executive Officers

Senior Vice Presidents

Executive Vice Presidents

Vice Presidents

Global Heads

Directors

Executive Director

Responsible For:

Quality

Quality Operations

Biomanufacturing Operations

Quality Risk Management

Process Research & Development

Bioprocess R&D

Validation Manufacturing Science & Technology

Process Design

Technical Operations

Product Supply

Quality Assurance

Quality Compliance

See Which Topics Are Discussed at the Strategy Meeting

REGISTRATION AND WELCOME

OPENING KEYNOTE PRESENTATION An overview of biologics supplies also in light of the pandemic challenges and emergence of multiple new biologics modality

Roundtable

Roundtable Tracks

Aligning Quality Systems With Evolving Global Health Authority Expectations

Exploring The Latest Revolution In Upstream Processing For Flexibility And Cost-Effectivity Leading To Higher Yields

Pharma 4.0: How To Effectively Integrate Advanced Process Control Based on Digital Twins Combined With Process Analytical Technology For Real-Time Release Testing (RTRT)

Addressing The Challenges In Manufacturing New Biologic Modalities: Viral Vectors, ADCs, RNA, and Cell Therapies To Build A Viable Commercial Production

NETWORKING / 1-1 MEETINGS

NETWORKING / 1-1 MEETINGS

NETWORKING / 1-1 MEETINGS

Roundtable

Roundtable Tracks

Embracing The Best Strategy To Mitigate Risk And Achieve Product & Process Consistency In Place Of External Conditions Such As The Pandemic, Changing Regulations, Or Other Unseen Constraints

Looking Into Highly-Effective Tools And Techniques To Maximise Quality Output In DSP Processing

Exploring The Opportunities To Build A Cost-Effective GMP Cloud Computing Without The Need To Sacrifice Data Integrity

Understanding The Crucial Part Of Biomanufacturing To Lessen The Cost Of Advanced Therapies

NETWORKING LUNCH

Reasons To Attend the Strategy Meeting

Our 2022 Co-Hosts

Press play to hear what your colleagues had to say…

Become an official strategy meeting partner

Here To Help

Want to find out more?

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

Radisson Blu Hotel, Zurich Airport

OPENING KEYNOTE PRESENTATION
An overview of biologics supplies also in light of the pandemic challenges and emergence of multiple new biologics modality